Today: 5 June 2026

Shan Ahmed Khan

As a journalist focused on finance and the stock market, he delivers fast, reliable, and easy-to-understand coverage of market news.

BHP share price drops 2% as copper whipsaws and rate bets build — what to watch next

BHP share price drops 2% as copper whipsaws and rate bets build — what to watch next

BHP shares fell 2.0% to A$50.46 on Friday, ending a two-day rally as the S&P/ASX 200 dropped 0.65%. Copper surged to a record $14,527.50 a tonne on Thursday before retreating, driven by speculative trading in China. Australian core inflation rose 0.9% last quarter, raising odds of a February rate hike to 73%. BHP made no new announcements last week ahead of its mid-February earnings release.
30 January 2026
·
NAB share price rises as rate-hike bets build — what investors watch next week

NAB share price rises as rate-hike bets build — what investors watch next week

NAB shares rose 0.7% to A$43.34 Friday, bucking a 0.7% drop in the S&P/ASX 200 after inflation data raised expectations of a Reserve Bank rate hike on Feb. 3. Markets now price in a 73% chance of a move. NAB’s first-quarter trading update is set for Feb. 18. The bank also plans to shift 110 digital messaging jobs to India, offering affected Australian staff alternative roles.
30 January 2026
··
Lynas Rare Earths stock slides after U.S. price-floor rethink — what to watch next for ASX:LYC

Lynas Rare Earths stock slides after U.S. price-floor rethink — what to watch next for ASX:LYC

Lynas Rare Earths shares fell 4.5% to A$14.90 Friday, extending a sector-wide slump after reports the U.S. may drop plans for minimum price guarantees on critical minerals. Australia’s government pledged continued support, with a A$1.2 billion strategic reserve still planned. U.S.-listed rare-earth stocks also declined. The U.S. Energy Department denied it is abandoning price floors.
30 January 2026
·
Denali Therapeutics stock price rises as FDA freezes rival Regenxbio’s Hunter syndrome gene therapy trials

Denali Therapeutics stock price rises as FDA freezes rival Regenxbio’s Hunter syndrome gene therapy trials

Denali Therapeutics shares rose 3.7% to $21.62 Thursday after the FDA halted Regenxbio’s gene therapy trials over a brain tumor case, intensifying focus on Denali’s Hunter syndrome drug under FDA review. Investors await Denali’s clinical data update in early February and a regulatory decision by April 5. The iShares Nasdaq Biotechnology ETF was little changed.
29 January 2026
····
IBM stock rises after earnings beat, as Wall Street zeroes in on Red Hat and Washington risk

IBM stock rises after earnings beat, as Wall Street zeroes in on Red Hat and Washington risk

IBM shares rose 3.3% to $304.01 Thursday after reporting fourth-quarter revenue of $19.7 billion and adjusted earnings of $4.52 per share, beating forecasts. The gain contrasted with declines in other software stocks as investors questioned AI investment returns. Red Hat growth slowed to 10%, partly due to a U.S. government shutdown. IBM will stop reporting its “AI book of business” separately starting next quarter.
29 January 2026
···
Olema Pharmaceuticals (OLMA) stock jumps 6% in a weak market — what to watch next

Olema Pharmaceuticals (OLMA) stock jumps 6% in a weak market — what to watch next

Olema Pharmaceuticals shares rose 5.8% to $25.99 Thursday afternoon, adding about $127 million in market value as broader indexes fell. Trading volume reached 926,000 shares. No new company news emerged, but traders are watching for Olema’s March update and progress on its late-stage palazestrant trial. The company reported over $500 million in cash and equivalents as of Dec. 31, 2025.
29 January 2026
··
Lockheed Martin stock price jumps on Pentagon profit-share missile deal and upbeat 2026 outlook

Lockheed Martin stock price jumps on Pentagon profit-share missile deal and upbeat 2026 outlook

Lockheed Martin shares rose 4.7% to $625.61 after the Pentagon signed a profit-sharing deal to ramp up THAAD and Patriot interceptor production. The company’s 2026 revenue and profit forecast topped Wall Street estimates. Lockheed reported Q4 sales of $20.32 billion and net earnings of $1.3 billion. Investors are watching whether funding and factory capacity can meet higher output targets.
29 January 2026
··
Norwegian Cruise Line stock jumps nearly 10% as Royal Caribbean outlook lifts cruise shares

Norwegian Cruise Line stock jumps nearly 10% as Royal Caribbean outlook lifts cruise shares

Norwegian Cruise Line Holdings shares jumped nearly 10% to $22.86 Thursday as cruise stocks rallied after Royal Caribbean issued an upbeat 2026 profit forecast and strong “Wave” booking commentary. About 20 million Norwegian shares changed hands by early afternoon. Oil prices surged nearly 4% to a five-month high, raising cost concerns for cruise operators. Norwegian has not issued new financial updates this week.
29 January 2026
···
Meta stock jumps nearly 10% after earnings, even with $135 billion AI spending plan

Meta stock jumps nearly 10% after earnings, even with $135 billion AI spending plan

Meta shares surged 10% to $735.36 Thursday after reporting a 24% jump in Q4 revenue to $59.89 billion, fueled by strong ad sales. The company forecast 2026 capital expenditures of $115–$135 billion, far above 2025 levels, to support AI expansion. Investors weighed the results against rising costs and legal risks. Meta also warned of regulatory challenges in its SEC filing.
29 January 2026
····
Brookdale Senior Living stock jumps on early 2025 results and fresh 2026 outlook ahead of Investor Day

Brookdale Senior Living stock jumps on early 2025 results and fresh 2026 outlook ahead of Investor Day

Brookdale Senior Living shares surged nearly 11% Thursday after releasing preliminary 2025 results and its first full-year 2026 forecast. The company projects 2026 adjusted EBITDA of $502 million to $516 million and expects RevPAR growth of 8% to 9%. Brookdale reported a 2025 net loss of about $263 million, including $71 million in non-cash impairment charges. Wall Street analysts raised price targets ahead of Investor Day.
29 January 2026
··
Virtu Financial stock price jumps after blowout Q4; traders eye volatility next

Virtu Financial stock price jumps after blowout Q4; traders eye volatility next

Virtu Financial shares rose 5.9% to $39.72 after the company reported fourth-quarter net income of $280.6 million on $969.9 million in revenue. Trading income jumped 22.2% year-over-year to $664.9 million amid higher market volatility and volumes. The board declared a $0.24 per share dividend, payable March 16 to holders as of Feb. 27. Virtu ended 2025 with $1.13 billion in cash and $2.07 billion in long-term debt.
29 January 2026
··
Carnival (CCL) stock price jumps as Royal Caribbean’s upbeat outlook lifts cruise shares

Carnival (CCL) stock price jumps as Royal Caribbean’s upbeat outlook lifts cruise shares

Carnival shares jumped 8.6% to $31.19 Thursday after Royal Caribbean projected 2026 profits above expectations and reported strong bookings. Royal Caribbean soared 17.1%, Norwegian Cruise Line rose 10%, and Viking Holdings gained 5.2%. Carnival will pay a 15-cent dividend on Feb. 27 to holders as of Feb. 13. Investors await Carnival’s earnings update, expected around March 20, for details on bookings and costs.
29 January 2026
····
1 … 123 124 125 126 127 … 587

Stock Market Today

  • Dollar Hits 1.75-Month High on Strong US Jobs Data and Market Uncertainty
    June 5, 2026, 1:07 PM EDT. The US dollar index surged 0.35% to a 1.75-month peak, supported by a stronger-than-expected May nonfarm payroll increase of 172,000 jobs versus 88,000 expected. April's jobs data was revised up to 179,000 from 115,000, reinforcing speculation of a Fed interest rate hike in June. The unchanged 4.3% unemployment rate and steady average hourly earnings added to dollar strength. Risk aversion amid stalled US-Iran peace talks and Middle East tensions also boosted demand for the dollar as a safe-haven currency. The euro dropped 0.47% on downward GDP revisions and expectations of an ECB rate hike. The yen fell to a five-week low against the dollar despite positive Japanese labor and spending data, with intervention risks rising as USD/JPY nears the 160 threshold.

Latest articles

Chipotle Up on JPMorgan Upgrade, Tough Test Still Looms

Chipotle Up on JPMorgan Upgrade, Tough Test Still Looms

5 June 2026
Chipotle shares jumped 4.8% to $29.54 after JPMorgan upgraded the stock to Overweight with a $35 target, citing “much more risk-weighted upside than downside” at current levels following a rare valuation reset after a six-day losing streak.
Planet Labs Drops After $1.5 Billion Filing

Planet Labs Drops After $1.5 Billion Filing

5 June 2026
Planet Labs plunged 22% to $33.86 after announcing a $1.5 billion at-the-market share-sale program, sparking dilution fears despite record Q1 revenue up 42% to $94.2 million and raised full-year guidance; analysts remain split, with Needham upping its price target to $53, while the average target sits below the current price even after the drop.
BlackBerry Shares Stall After QNX Push

BlackBerry Shares Stall After QNX Push

5 June 2026
BlackBerry shares plunged 8% after a rapid rally pushed the stock near a 52-week high, with investors now awaiting June 25 earnings to see if growth matches the hype; analyst price targets remain far below current levels, raising risk if QNX or secure communications disappoint.
Mortgage Rates Ease Some, Demand Remains Weak

Mortgage Rates Ease Some, Demand Remains Weak

5 June 2026
U.S. mortgage rates dipped to 6.48% but failed to revive buyer demand, with mortgage applications down 2.5% and purchase applications at their slowest pace since April, as high borrowing costs and tight budgets continue to weigh on the spring housing market despite a 2.4% drop in median list prices, according to Freddie Mac, MBA, and Realtor.com.
Marvell Shares Fall After Strong AI Run, S&P 500 Spot Up Next

Marvell Shares Fall After Strong AI Run, S&P 500 Spot Up Next

5 June 2026
Marvell shares plunged 7.4% to $292.88 amid a broad chip selloff and uncertainty over possible S&P 500 inclusion after the close, despite a recent AI-driven surge and record quarterly revenue; investors are weighing index decision risks and volatile AI sentiment as Marvell’s market cap stays above $260 billion.
Go toTop